» Articles » PMID: 6510434

The Effect of Intravenous L-carnitine on Propionic Acid Excretion in Acute Propionic Acidaemia

Overview
Journal Eur J Pediatr
Specialty Pediatrics
Date 1984 Nov 1
PMID 6510434
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

A 6-week-old female infant presented in a severe metabolic crisis from propionic acidaemia. The condition was aggravated by pneumonia and heart insufficiency. In addition to the general supportive measures and caloric intake exclusively from glucose, intravenous L-carnitine treatment (2 g L-carnitine/24 h) was started to enhance propionic acid excretion as a carnitine conjugate. Despite the therapeutic efforts the patient died about 48 h after admission in sudden respiratory arrest and bradycardia. Serum propionic acid concentration was increased to 0.3 mumol/ml. Propionylcarnitine excretion was measured and about 55% of the overall excretion during the 48 h treatment period was attributed to an effect of carnitine administration. 2-methylcitrate and 2-methyl-3-oxovaleric acid excretion decreased during the same period. Obviously carnitine was not able to prevent metabolic deterioration but may provide some additional "buffer capacity" during long-term dietary treatment.

Citing Articles

Propionic acidaemia: clinical, biochemical and therapeutic aspects. Experience in 30 patients.

Lehnert W, Sperl W, Suormala T, Baumgartner E Eur J Pediatr. 1994; 153(7 Suppl 1):S68-80.

PMID: 7957390 DOI: 10.1007/BF02138781.


Effects of propionate and carnitine on the hepatic oxidation of short- and medium-chain-length fatty acids.

Brass E, Beyerinck R Biochem J. 1988; 250(3):819-25.

PMID: 3134008 PMC: 1148929. DOI: 10.1042/bj2500819.


Haemodialysis for metabolic decompensation in propionic acidaemia.

Roth B, Skopnik H, Leonard J, Lehnert W J Inherit Metab Dis. 1987; 10(2):147-51.

PMID: 3116333 DOI: 10.1007/BF01800040.

References
1.
McGarry J, Foster D . An improved and simplified radioisotopic assay for the determination of free and esterified carnitine. J Lipid Res. 1976; 17(3):277-81. View

2.
Duran M, GOMPERTZ D, Bruinvis L, Ketting D, WADMAN S . The variability of metabolite excretion in propionicacidaemia. Clin Chim Acta. 1978; 82(1-2):93-9. DOI: 10.1016/0009-8981(78)90030-x. View

3.
Cheema-Dhadli S, Leznoff C, Halperin M . Effect of 2-methylcitrate on citrate metabolism: implications for the management of patients with propionic acidemia and methylmalonic aciduria. Pediatr Res. 1975; 9(12):905-8. DOI: 10.1203/00006450-197512000-00008. View

4.
Seccombe D, Snyder F, Parsons H . L-carnitine for methylmalonicaciduria. Lancet. 1982; 2(8312):1401. DOI: 10.1016/s0140-6736(82)91300-9. View

5.
Allen R, Hansch D, Wu H . Hypocarnitinemia in disorders of organic acid metabolism. Lancet. 1982; 2(8296):500-1. DOI: 10.1016/s0140-6736(82)90532-3. View